198 results
424B5
RVNC
Revance Therapeutics Inc
5 Mar 24
Prospectus supplement for primary offering
5:00pm
in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.
Special … by the applicable prospectus supplement. When a global security terminates, the depositary, and neither we nor any applicable trustee, is responsible
424B5
im6oxau4fhnp1q0drc
4 Mar 24
Prospectus supplement for primary offering
6:39am
8-K
EX-10.2
f73zm
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
60aqgu
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
0z4fgsgv02laoms
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
S-3ASR
6fhkbwn 5k5
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
EX-4.7
d44jzt
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
EX-4.8
6aiztcl9 flg
14 Nov 23
Automatic shelf registration
4:22pm
S-3ASR
EX-4.6
gcrr9pacic 2l6342fw6
14 Nov 23
Automatic shelf registration
4:22pm